Risk Factor Assessment for the Acquisition of Fluoroquinolone-Resistant Isolates of Pseudomonas aeruginosa in a Community-Based Hospital-Reference-Cited by-同舟云学术

Risk Factor Assessment for the Acquisition of Fluoroquinolone-Resistant Isolates of Pseudomonas aeruginosa in a Community-Based Hospital

Published:1995-01 Issue:3 Volume:1 Page:219-222
ISSN:1076-6294
Container-title:Microbial Drug Resistance
language:en
Short-container-title:Microbial Drug Resistance

Author:

BADDOUR LARRY M.,HICKS DEREK V.,TAYIDI MANDANA M.,ROBERTS SHANNON K.,WALKER ESTEBAN,SMITH RUSSELL J.,SWEITZER DONNA S.,HERRINGTON JANET A.,PAINTER BARBARA G.

Publisher

Mary Ann Liebert Inc

Subject

Microbiology (medical),Pharmacology,Immunology,Microbiology

Link

http://www.liebertpub.com/doi/pdf/10.1089/mdr.1995.1.219

Reference7 articles.

1. Rapid Development of Ciprofloxacin Resistance in Methicillin-Susceptible and -Resistant Staphylococcus aureus

2. Emergence of Quinolone-Resistant Escherichia coli Bacteremia in Neutropenic Patients with Cancer Who Have Received Prophylactic Norfloxacin

3. Ciprofloxacin Resistance among Nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States

4. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center

5. Fluoroquinolone Use and Fluoroquinolone Resistance: Is There an Association?

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel method of calculating adjusted antibiotic use by microbiological burden;Infection Control & Hospital Epidemiology;2021-01-28

2. In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes—Study for Monitoring Antimicrobial Resistance Trends, United States 2015–2017;Clinical Infectious Diseases;2020-04-03

3. Risk Factors for gyrA and parC Mutations in Pseudomonas aeruginosa;Infection Control & Hospital Epidemiology;2015-01-23

4. Risk factors for bacteraemia attributable to Pseudomonas aeruginosa resistant to imipenem, levofloxacin, or gentamicin;Journal of Hospital Infection;2011-11

5. Épidémiologie des infections à Pseudomonas aeruginosa;Revue Francophone des Laboratoires;2011-09